Open AccessIbrutinib treatment ameliorates murine chronic graft-versus-host disease
Author(s) -
Jason A. Dubovsky,
Ryan T. Flynn,
Junbao Du,
Bonnie K. Harrington,
Zhong Ye,
Benjamin H. Kaffenberger,
Carrie Yang,
William H. Towns,
Amy Lehman,
Amy J. Johnson,
Natarajan Muthusamy,
Steven M. Devine,
Samantha Jaglowski,
Jonathan S. Serody,
William J. Murphy,
David H. Munn,
Leo Luznik,
Geoffrey R. Hill,
Henry K. Wong,
Kelli P. A. MacDonald,
Ivan Maillard,
John Koreth,
Laurence Elias,
Corey Cutler,
Robert J. Soiffer,
Joseph H. Antin,
Jérôme Ritz,
Angela PanoskaltsisMortari,
John C. Byrd,
Bruce R. Blazar
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/vfd1-7m89
Subject(s) - ibrutinib , graft versus host disease , medicine , host (biology) , disease , oncology , biology , leukemia , chronic lymphocytic leukemia , ecology